Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201

References

• Calder PC, Harwood J, Lloyd-Evans E. Eicosanoids. Essays Biochem. 2020;64(3):423–441. doi:10.1042/EBC20190083
   PubMed Web of Science ®Google Scholar
• Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92–101. doi:10.1038/nature13479
   PubMed Web of Science ®Google Scholar
• Astudillo AM, Balboa MA, Balsinde J. Selectivity of phospholipid hydrolysis by phospholipase A2 enzymes in activated cells leading to polyunsaturated fatty acid mobilization. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(6):772–783. doi:10.1016/j.bbalip.2018.07.002
   PubMed Web of Science ®Google Scholar
• Chiang N, Serhan CN, Harwood J, Lloyd-Evans E. Specialized pro-resolving mediator network: an update on production and actions. Essays Biochem. 2020;64(3):443–462. doi:10.1042/EBC20200018
   PubMed Web of Science ®Google Scholar
• Dennis EA, Norris PC. Eicosanoid storm in infection and inflammation. Nat Rev Immunol. 2015;15(8):511–523. doi:10.1038/nri3859
   PubMed Web of Science ®Google Scholar
• Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294(5548):1871–1875. doi:10.1126/science.294.5548.1871
   PubMed Web of Science ®Google Scholar
• Smith WL, Urade Y, Jakobsson PJ. Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem Rev. 2011;111(10):5821–5865. doi:10.1021/cr2002992
   PubMed Web of Science ®Google Scholar
• Radmark O, Werz O, Steinhilber D, Samuelsson B. 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease. Biochim Biophys Acta. 2015;1851(4):331–339. doi:10.1016/j.bbalip.2014.08.012
   PubMed Web of Science ®Google Scholar
• Haeggstrom JZ. Leukotriene biosynthetic enzymes as therapeutic targets. J Clin Invest. 2018;128(7):2680–2690. doi:10.1172/JCI97945
   PubMed Web of Science ®Google Scholar
• Peters-Golden M, Henderson WR Jr. Leukotrienes. N Engl J Med. 2007;357(18):1841–1854. doi:10.1056/NEJMra071371
   PubMed Web of Science ®Google Scholar
• Gur ZT, Caliskan B, Banoglu E. Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis. Eur J Med Chem. 2018;153:34–48. doi:10.1016/j.ejmech.2017.07.019
   PubMed Web of Science ®Google Scholar
• Pettersen D, Davidsson O, Whatling C. Recent advances for FLAP inhibitors. Bioorg Med Chem Lett. 2015;25(13):2607–2612. doi:10.1016/j.bmcl.2015.04.090
   PubMed Web of Science ®Google Scholar
• Werner M, Jordan PM, Romp E, et al. Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome. FASEB J. 2019;33(5):6140-6153. doi: 10.1096/fj.201802509R
   PubMed Web of Science ®Google Scholar
• Werz O, Gerstmeier J, Libreros S, et al. Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity. Nat Commun. 2018;9(1):59. doi:10.1038/s41467-017-02538-5
   PubMed Web of Science ®Google Scholar
• Lehmann C, Homann J, Ball AK, et al. Lipoxin and resolvin biosynthesis is dependent on 5-lipoxygenase activating protein. FASEB J. 2015;29(12):5029–5043. doi:10.1096/fj.15-275487
   PubMed Web of Science ®Google Scholar
• Fredman G, Ozcan L, Spolitu S, et al. Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway. Proc Natl Acad Sci USA. 2014;111(40):14530–14535. doi:10.1073/pnas.1410851111
   PubMed Web of Science ®Google Scholar
• Mahesh G, Anil Kumar K, Reddanna P. Overview on the discovery and development of anti-inflammatory drugs: should the focus be on synthesis or degradation of PGE2? J Inflamm Res. 2021;14:253–263. doi:10.2147/JIR.S278514
   PubMed Web of Science ®Google Scholar
• Rainsford KD. Anti-inflammatory drugs in the 21st century. Subcell Biochem. 2007;42:3–27.
   PubMedGoogle Scholar
• Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest. 2018;128(7):2657–2669. doi:10.1172/JCI97943
   PubMed Web of Science ®Google Scholar
• Gilbert NC, Newcomer ME, Werz O. Untangling the web of 5-lipoxygenase-derived products from a molecular and structural perspective: the battle between pro- and anti-inflammatory lipid mediators. Biochem Pharmacol. 2021;193:114759. doi:10.1016/j.bcp.2021.114759
   PubMed Web of Science ®Google Scholar
• Gur ZT, Caliskan B, Garscha U, et al. Identification of multi-target inhibitors of leukotriene and prostaglandin E2 biosynthesis by structural tuning of the FLAP inhibitor BRP-7. Eur J Med Chem. 2018;150:876–899. doi:10.1016/j.ejmech.2018.03.045
   PubMed Web of Science ®Google Scholar
• Gilbert NC, Gerstmeier J, Schexnaydre EE, et al. Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products. Nat Chem Biol. 2020;16(7):783–790. doi:10.1038/s41589-020-0544-7
   PubMed Web of Science ®Google Scholar
• Jordan PM, Gerstmeier J, Pace S, et al. Staphylococcus aureus-derived alpha-hemolysin evokes generation of specialized pro-resolving mediators promoting inflammation resolution. Cell Rep. 2020;33(2):108247. doi:10.1016/j.celrep.2020.108247
   PubMed Web of Science ®Google Scholar
• He C, Wu Y, Lai Y, Cai Z, Liu Y, Lai L. Dynamic eicosanoid responses upon different inhibitor and combination treatments on the arachidonic acid metabolic network. Mol Biosyst. 2012;8(5):1585–1594. doi:10.1039/c2mb05503a
   PubMedGoogle Scholar
• Werz O, Gerstmeier J, Garscha U. Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agents. Expert Opin Ther Pat. 2017;27(5):607–620. doi:10.1080/13543776.2017.1276568
   PubMed Web of Science ®Google Scholar
• Ivanov I, Kuhn H, Heydeck D. Structural and functional biology of arachidonic acid 15-lipoxygenase-1 (ALOX15). Gene. 2015;573(1):1–32. doi:10.1016/j.gene.2015.07.073
   PubMed Web of Science ®Google Scholar
• Gerstmeier J, Weinigel C, Barz D, Werz O, Garscha U. An experimental cell-based model for studying the cell biology and molecular pharmacology of 5-lipoxygenase-activating protein in leukotriene biosynthesis. Biochim Biophys Acta. 2014;1840(9):2961–2969. doi:10.1016/j.bbagen.2014.05.016
   PubMed Web of Science ®Google Scholar
• Pace S, Zhang K, Jordan PM, et al. Anti-inflammatory celastrol promotes a switch from leukotriene biosynthesis to formation of specialized pro-resolving lipid mediators. Pharmacol Res. 2021;167:105556. doi:10.1016/j.phrs.2021.105556
   PubMed Web of Science ®Google Scholar
• Patrono C, Baigent C. Coxibs, traditional NSAIDs, and cardiovascular safety post-PRECISION: what we thought we knew then and what we think we know now. Clin Pharmacol Ther. 2017;102(2):238–245. doi:10.1002/cpt.696
   PubMed Web of Science ®Google Scholar
• Sala A, Proschak E, Steinhilber D, Rovati GE. Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade. Biochem Pharmacol. 2018;158:161–173. doi:10.1016/j.bcp.2018.10.007
   PubMed Web of Science ®Google Scholar
• Patrignani P, Patrono C. Cyclooxygenase inhibitors: from pharmacology to clinical read-outs. Biochim Biophys Acta. 2015;1851(4):422–432. doi:10.1016/j.bbalip.2014.09.016
   PubMed Web of Science ®Google Scholar
• Koeberle A, Werz O. Natural products as inhibitors of prostaglandin E2 and pro-inflammatory 5-lipoxygenase-derived lipid mediator biosynthesis. Biotechnol Adv. 2018;36(6):1709–1723. doi:10.1016/j.biotechadv.2018.02.010
   PubMed Web of Science ®Google Scholar
• Dalli J. Does promoting resolution instead of inhibiting inflammation represent the new paradigm in treating infections? Mol Aspects Med. 2017;58:12–20. doi:10.1016/j.mam.2017.03.007
   PubMed Web of Science ®Google Scholar
• Cheung SY, Werner M, Esposito L, et al. Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase that favorably modulates lipid mediator biosynthesis in inflammation. Eur J Med Chem. 2018;156:815–830. doi:10.1016/j.ejmech.2018.07.031
   PubMed Web of Science ®Google Scholar
• Gerstmeier J, Kretzer C, Di Micco S, et al. Novel benzoxanthene lignans that favorably modulate lipid mediator biosynthesis: a promising pharmacological strategy for anti-inflammatory therapy. Biochem Pharmacol. 2019;165:263–274. doi:10.1016/j.bcp.2019.03.003
   PubMed Web of Science ®Google Scholar
• Van Anh TT, Mostafa A, Rao Z, et al. From Vietnamese plants to a biflavonoid that relieves inflammation by triggering the lipid mediator class switch to resolution. Acta Pharm Sin B. 2021;11(6):1629–1647. doi:10.1016/j.apsb.2021.04.011
   PubMed Web of Science ®Google Scholar
• Zhang K, Pace S, Jordan PM, et al. Beneficial modulation of lipid mediator biosynthesis in innate immune cells by antirheumatic Tripterygium wilfordii glycosides. Biomolecules. 2021;11(5):746. doi:10.3390/biom11050746
   PubMed Web of Science ®Google Scholar
• Werz O, Steinhilber D. Development of 5-lipoxygenase inhibitors–lessons from cellular enzyme regulation. Biochem Pharmacol. 2005;70(3):327–333. doi:10.1016/j.bcp.2005.04.018
   PubMed Web of Science ®Google Scholar
• Kuhn H, Humeniuk L, Kozlov N, Roigas S, Adel S, Heydeck D. The evolutionary hypothesis of reaction specificity of mammalian ALOX15 orthologs. Prog Lipid Res. 2018;72:55–74. doi:10.1016/j.plipres.2018.09.002
   PubMed Web of Science ®Google Scholar
• Gerstmeier J, Weinigel C, Rummler S, Radmark O, Werz O, Garscha U. Time-resolved in situ assembly of the leukotriene-synthetic 5-lipoxygenase/5-lipoxygenase-activating protein complex in blood leukocytes. FASEB J. 2016;30(1):276–285. doi:10.1096/fj.15-278010
   PubMed Web of Science ®Google Scholar
• Titos E, Claria J, Planaguma A, et al. Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells. J Leukoc Biol. 2005;78(4):871–878. doi:10.1189/jlb.1204747
   PubMed Web of Science ®Google Scholar
• Meng H, McClendon CL, Dai Z, et al. Discovery of novel 15-Lipoxygenase activators to shift the human arachidonic acid metabolic network toward inflammation resolution. J Med Chem. 2016;59(9):4202–4209. doi:10.1021/acs.jmedchem.5b01011
   PubMed Web of Science ®Google Scholar
• Meng H, Dai Z, Zhang W, Liu Y, Lai L. Molecular mechanism of 15-lipoxygenase allosteric activation and inhibition. Phys Chem Chem Phys. 2018;20(21):14785–14795. doi:10.1039/C7CP08586A
   PubMed Web of Science ®Google Scholar